Several of the events took place at ‘upscale restaurants’ in San Francisco, at costs of up to $163 per person, according to ...

Tamar Braxton has announced a new brand partnership with Gilead Sciences. The music veteran will help educate and raise ...

Globally, an estimated 4,000 adolescent girls and young women become infected with HIV each week, with sub-Saharan Africa accounting for more than 60% of these new infections, according to the World ...

WHO endorses biannual injectable Lenacapavir for HIV prevention. This long-acting PrEP offers hope for high-risk groups and ...

HOOKIPA Pharma Inc. (NASDAQ: HOOK, 'HOOKIPA”), a clinical-stage biopharmaceutical company developing next-generation ...

The investigational oral pre-exposure prophylaxis (PrEP) agent MK-8527 showed a similar, well-tolerated safety profile to placebo, with dose-proportional pharmacokinetics, among adults with a low ...

Health clinics that serve more than 1.1 million patients up and down the San Joaquin Valley are bracing for the prospect of budget cuts and other fallout in the wake of the passage of President Donald ...

A major HIV drug maker will return $202 million nationwide after a multi-year investigation and settlement. Pharmaceutical ...

South Africa will buy lenacapavir using Global Fund money. Studies show it can stop infections entirely in young women. But ...